Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

When science and art commingle in a botanical illustration, it’s as if a magical world appears, where colors, brushstrokes, ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...